151 related articles for article (PubMed ID: 26103574)
1. Dual inhibition of survivin and MAOA synergistically impairs growth of PTEN-negative prostate cancer.
Xu S; Adisetiyo H; Tamura S; Grande F; Garofalo A; Roy-Burman P; Neamati N
Br J Cancer; 2015 Jul; 113(2):242-51. PubMed ID: 26103574
[TBL] [Abstract][Full Text] [Related]
2. Loss of MAOA in epithelia inhibits adenocarcinoma development, cell proliferation and cancer stem cells in prostate.
Liao CP; Lin TP; Li PC; Geary LA; Chen K; Vaikari VP; Wu JB; Lin CH; Gross ME; Shih JC
Oncogene; 2018 Sep; 37(38):5175-5190. PubMed ID: 29844571
[TBL] [Abstract][Full Text] [Related]
3. Monoamine oxidase A inhibitor-near-infrared dye conjugate reduces prostate tumor growth.
Wu JB; Lin TP; Gallagher JD; Kushal S; Chung LW; Zhau HE; Olenyuk BZ; Shih JC
J Am Chem Soc; 2015 Feb; 137(6):2366-74. PubMed ID: 25585152
[TBL] [Abstract][Full Text] [Related]
4. MAOA-a novel decision maker of apoptosis and autophagy in hormone refractory neuroendocrine prostate cancer cells.
Lin YC; Chang YT; Campbell M; Lin TP; Pan CC; Lee HC; Shih JC; Chang PC
Sci Rep; 2017 Apr; 7():46338. PubMed ID: 28402333
[TBL] [Abstract][Full Text] [Related]
5. Targeting survivin using a combination of miR‑494 and survivin shRNA has synergistic effects on the suppression of prostate cancer growth.
Zhu J; Sun C; Wang L; Xu M; Zang Y; Zhou Y; Liu X; Tao W; Xue B; Shan Y; Yang D
Mol Med Rep; 2016 Feb; 13(2):1602-10. PubMed ID: 26718651
[TBL] [Abstract][Full Text] [Related]
6. Targeting monoamine oxidase A in advanced prostate cancer.
Flamand V; Zhao H; Peehl DM
J Cancer Res Clin Oncol; 2010 Nov; 136(11):1761-71. PubMed ID: 20204405
[TBL] [Abstract][Full Text] [Related]
7. Monoamine oxidase A (MAOA): A promising target for prostate cancer therapy.
Han H; Li H; Ma Y; Zhao Z; An Q; Zhao J; Shi C
Cancer Lett; 2023 Jun; 563():216188. PubMed ID: 37076041
[TBL] [Abstract][Full Text] [Related]
8. Mitochondria-targeted prostate cancer therapy using a near-infrared fluorescence dye-monoamine oxidase A inhibitor conjugate.
Lv Q; Yang X; Wang M; Yang J; Qin Z; Kan Q; Zhang H; Wang Y; Wang D; He Z
J Control Release; 2018 Jun; 279():234-242. PubMed ID: 29679664
[TBL] [Abstract][Full Text] [Related]
9. Monoamine oxidase A mediates prostate tumorigenesis and cancer metastasis.
Wu JB; Shao C; Li X; Li Q; Hu P; Shi C; Li Y; Chen YT; Yin F; Liao CP; Stiles BL; Zhau HE; Shih JC; Chung LW
J Clin Invest; 2014 Jul; 124(7):2891-908. PubMed ID: 24865426
[TBL] [Abstract][Full Text] [Related]
10. MAOA-mediated reprogramming of stromal fibroblasts promotes prostate tumorigenesis and cancer stemness.
Li J; Pu T; Yin L; Li Q; Liao CP; Wu BJ
Oncogene; 2020 Apr; 39(16):3305-3321. PubMed ID: 32066880
[TBL] [Abstract][Full Text] [Related]
11. [Expression and significance of survivin protein, PTEN in prostatic cancer].
Xia XY; Li LH; Li XC; Jang T
Zhonghua Nan Ke Xue; 2006 Apr; 12(4):346-8, 351. PubMed ID: 16683571
[TBL] [Abstract][Full Text] [Related]
12. Akt down-modulation induces apoptosis of human prostate cancer cells and synergizes with EGFR tyrosine kinase inhibitors.
Festuccia C; Gravina GL; Muzi P; Millimaggi D; Dolo V; Vicentini C; Bologna M
Prostate; 2008 Jun; 68(9):965-74. PubMed ID: 18361408
[TBL] [Abstract][Full Text] [Related]
13. Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines.
Festuccia C; Muzi P; Millimaggi D; Biordi L; Gravina GL; Speca S; Angelucci A; Dolo V; Vicentini C; Bologna M
Endocr Relat Cancer; 2005 Dec; 12(4):983-98. PubMed ID: 16322337
[TBL] [Abstract][Full Text] [Related]
14. Monoamine Oxidase Deficiency Causes Prostate Atrophy and Reduces Prostate Progenitor Cell Activity.
Yin L; Li J; Liao CP; Jason Wu B
Stem Cells; 2018 Aug; 36(8):1249-1258. PubMed ID: 29637670
[TBL] [Abstract][Full Text] [Related]
15. Monoamine oxidase A suppresses hepatocellular carcinoma metastasis by inhibiting the adrenergic system and its transactivation of EGFR signaling.
Li J; Yang XM; Wang YH; Feng MX; Liu XJ; Zhang YL; Huang S; Wu Z; Xue F; Qin WX; Gu JR; Xia Q; Zhang ZG
J Hepatol; 2014 Jun; 60(6):1225-34. PubMed ID: 24607627
[TBL] [Abstract][Full Text] [Related]
16. Application of novel pH sensitive isoniazid-heptamethine carbocyanine dye conjugates against prostate cancer cells.
Yang XG; Li YF; Wang YJ; Kong RH; Wang D
Pharmazie; 2020 Sep; 75(9):412-416. PubMed ID: 32797765
[TBL] [Abstract][Full Text] [Related]
17. Monoamine oxidase-A targeting probe for prostate cancer imaging and inhibition of metastasis.
Kim WY; Won M; Salimi A; Sharma A; Lim JH; Kwon SH; Jeon JY; Lee JY; Kim JS
Chem Commun (Camb); 2019 Oct; 55(88):13267-13270. PubMed ID: 31621760
[TBL] [Abstract][Full Text] [Related]
18. MAOA promotes prostate cancer cell perineural invasion through SEMA3C/PlexinA2/NRP1-cMET signaling.
Yin L; Li J; Wang J; Pu T; Wei J; Li Q; Wu BJ
Oncogene; 2021 Feb; 40(7):1362-1374. PubMed ID: 33420365
[TBL] [Abstract][Full Text] [Related]
19. [Expression of survivin protein in prostatic carcinoma tissues and its correlation with apoptosis of cancer cells].
Gao W; Hu C; Yi M
Zhonghua Nan Ke Xue; 2004 Jan; 10(1):12-4. PubMed ID: 14979198
[TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis, and Evaluation of Monoamine Oxidase A Inhibitors⁻Indocyanine Dyes Conjugates as Targeted Antitumor Agents.
Yang XG; Mou YH; Wang YJ; Wang J; Li YY; Kong RH; Ding M; Wang D; Guo C
Molecules; 2019 Apr; 24(7):. PubMed ID: 30974737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]